You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endostatins

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in China (Endostatins, IMRT)

Unknown status
  • Nasopharyngeal Carcinoma
  • Endostatins
  • IMRT
  • Foshan, Guangdong, China
  • +7 more
Jan 31, 2021

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Colorectal Tumors Trial (Envafolimab, recombinant human endostatin (endostatin))

Not yet recruiting
  • Colorectal Neoplasms
  • (no location specified)
Sep 19, 2022

Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human

Recruiting
  • Optic Glioma
  • Pediatric Brain Tumor, Optic Nerve Glioma
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Jul 4, 2022

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

Nasopharyngeal Carcinoma Trial in China (Endostatin and Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostatin and Capecitabine
  • Hangzhou, Zhejiang, China
  • +6 more
Aug 21, 2022

Gastric/Gastroesophageal Junction Adenocarcinoma, Radiotherapy, Immunotherapy Trial (Envafolimab)

Not yet recruiting
  • Gastric/Gastroesophageal Junction Adenocarcinoma
  • +2 more
  • (no location specified)
May 18, 2022

Envafolimab Combined With Endostar and Concurrent

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
May 19, 2023

Advanced Pancreatic Cancer Trial in Xuzhou (Envafolimab, Endostar, Nab paclitaxel)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Mar 18, 2022

Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Endostatin
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
Jul 4, 2022

Squamous NSCLC Trial in Jinan ("Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin")

Recruiting
  • Squamous Non-small Cell Lung Cancer
  • "Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin"
  • Jinan, Shandong, China
  • +1 more
Feb 14, 2022

NSCLC Trial in Changsha (envafolimab)

Enrolling by invitation
  • Non-small Cell Lung Cancer
  • Changsha, Hunan, China
    the second Xiangya hospital
May 1, 2022

Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Envafolimab and recombinant human endostatin combined with chemoradiotherapy
  • (no location specified)
Sep 23, 2023

Non-Small-Cell Lung Cancer Trial in Jinan (Recombinant human endostatin (Endostar))

Recruiting
  • Non-Small-Cell Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Oct 8, 2022

Advanced or Metastatic NSCLC Trial in Shanghai (drug, device, combination product)

Not yet recruiting
  • Advanced or Metastatic NSCLC
  • Shanghai, Shanghai, China
    Lan Mu
Jun 29, 2021

Plasma Endostatin Predicts Outcome of Septic AKI

Completed
  • Acute Kidney Injury Due to Sepsis
  • measuring plasma Endostatin level
  • Cairo, Down Town, Egypt
    Farouk Faris
Nov 17, 2020

Lung Cancer Trial (Recombinant human endostatin (Endostar), Thoracic irradiation of 50 Gy with 3DCRT or IMRT)

Not yet recruiting
  • Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Thoracic irradiation of 50 Gy with 3DCRT or IMRT
  • (no location specified)
Oct 27, 2020

Other Disorders of Soft Tissues Trial in Shanghai (Endostar (recombinant human endostatin injection), Chemotherapy AI)

Recruiting
  • Other Disorders of Soft Tissues
  • Endostar (recombinant human endostatin injection)
  • Chemotherapy AI
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 6, 2021

Leptomeningeal Metastasis Trial (Recombinant Human Endostatin, intrathcal methotrexate, Targeted drugs for non-small cell lung

Not yet recruiting
  • Leptomeningeal Metastasis
  • Recombinant Human Endostatin
  • +2 more
  • (no location specified)
May 23, 2020

Solid Tumor Trial in Madison (recombinant human endostatin)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • recombinant human endostatin
  • Madison, Wisconsin
    University of Wisconsin Comprehensive Cancer Center
Dec 12, 2019

Staging IV NSCLC Trial in Guangzhou (Rh-endostatin)

Not yet recruiting
  • Staging IV NSCLC
  • Guangzhou, Guangdong, China
    Zhou Chengzhi
Feb 5, 2020

Soft Tissue Sarcoma, Adult, Stage IIB Trial in Tianjin (Endostar, Placebo, AIM regimen / GT regimen)

Completed
  • Soft Tissue Sarcoma, Adult, Stage IIB
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Hospital & Institute
Dec 23, 2019

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Paclitaxel+Nedaplatin+Endostar)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2019

Breast Cancer Trial in Hangzhou (Endostar, Chemotherapy)

Unknown status
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Apr 5, 2019